Context Therapeutics Inc. (CNTX): Weighted Average Diluted Shares
95.19M
Year ended 2025-12-31
+81.3%
3-year compound annual growth
+115.4%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 95.19M | +62.9% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | 58.42M | +265.9% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | 15.97M | 0.0% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | 15.97M | +463.4% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | 2.83M | +37.9% | 2023-03-22, From 2021-01-01 |
| 2020-12-31 | 2.05M | n/a | 2022-03-23, From 2020-01-01 |